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Abstract. Nephrogenic diabetes insipidus (NDI) is character­
ized by the inability of the kidney to concentrate urine in 
response to vasopressin. The autosomal recessive form of NDI 
is caused by mutations in the AQP2 gene, encoding the vaso­
pressin-regulated water channel of the kidney collecting duct. 
This report presents three new mutations in the AQP2 gene that 
cause NDI, resulting in A147T-, T126M-, or N68S-substituted 
AQP2 proteins. Expression of the A147T and T126M mutant 
AQP2 proteins in Xenopus oocytes revealed a relatively small, 
but significant increase in water permeability, whereas the 
water permeability of N68S expressing oocytes was not in­
creased. cRNA encoding missense and wild-type AQP2 were
Aquaporins are selective water channels and form a subset of 
the MIP family of intrinsic membrane proteins. In the kidney, 
four aquaporins (AQP 1 through 4) (1-6) have been identified 
and are postulated to be involved in reabsorption and concen­
tration of the glomerular filtrate. AQP1 is constitutively ex­
pressed in the proximal tubule and descending limb of Henle, 
and is localized to apical and basolateral membranes (7). AQP2 
is the vasopressin-regulated water channel of principal cells of 
the collecting duct (2). In the absence of vasopressin, AQP2 is 
localized in vesicles in the subapical region of the cell. Upon 
binding of vasopressin to its V2 receptor, AQP2 water channels 
are inserted into the apical membrane, conferring a high water 
permeability to this membrane. Upon removal of vasopressin, 
the channels are retrieved by endocytosis (8-12). AQP3 and 
AQP4 are localized to the basolateral membrane of principal 
cells of the collecting duct, and are suggested to function as an 
exit pathway for water (13). So far, only AQP2 has been shown 
to be involved in diseases. Individuals who lack functional
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equally stable in oocytes. Immunoblots of oocyte lysates 
showed that only the A147T mutant protein was less stable 
than wild-type AQP2. The mutant AQP2 proteins showed, in 
addition to the wild-type 29-kd band, an endoplasmic reticu­
lum-retarded form of AQP2 of approximately 32 kd. Immuno- 
blotting and immunocytochemistry demonstrated only intense 
labeling of the plasma membranes of oocytes expressing wild- 
type AQP2. In summary, two mutant AQP2 proteins encoded 
in NDI are functional water channels. Therefore, the major 
cause underlying autosomal recessive NDI is the misrouting of 
AQP2 mutant proteins. (J Am Soc Nephrol 8: 242-248, 1997)
AQP1 do not exhibit clinical symptoms, which raised ques­
tions about the physiological significance of AQP1 (14). Mu­
tations in AQP3 and AQP4 have not been identified so far. 
Mutations in the AQP2 gene, however, have been shown to be 
the cause of the autosomal recessive form of nephrogenic 
diabetes insipidus (NDI), a severe disease that is characterized 
by the inability of the kidney to concentrate urine in response 
to vasopressin (15,16). In the majority of patients, NDI is 
caused by a mutation in the V2 receptor gene, and is inherited 
as a X-linked recessive trait. In approximately 10% of the 
families, NDI has shown a non-X-linked pattern of inheritance. 
So far, a one-nucleotide deletion and three mutations coding 
for missense mutations in AQP2 have been reported as a cause 
of NDI in some of these families (15,16). Upon expression in 
Xenopus oocytes, the missense AQP2 proteins with a G64R, 
R187C, or S216P substitution were unable to increase the 
water permeability (Pf) of oocytes, whereas expression of wild 
type AQP2. increased Pf values more than 10-fold. Further 
studies revealed that the mutant AQP2 proteins were impaired 
in their cellular routing (17). Consequently, it remained unde­
cided whether these mutations resulted in non-functional water 
channels, since they did not reach the plasma membrane.
In the study presented here, we report three additional NDI 
patients who are homozygous for mutations in the AQP2 gene. 
In addition, we performed functional analyses of the mutant 
AQP2 proteins in oocytes and concluded that two mutations 
result in functional but misrouted water channels.
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Materials and Methods
Patients
The three patients investigated in this study come from three 
separate families from different ethnic origin, In all three families, the 
parents of the patients are consanguineous.
Family 1 is of Austrian descent, The male proband (Patient 1) was 
admitted to the hospital at the age of 3 months with signs of dehydration, 
including recurrent fever and hypernatremia (serum sodium concentra­
tion, 164 mmol/L). On admission, urinary osmolality was very low (50 
mosmol/kg) and did not increase after a water-deprivation test or after the 
administration of arginine vasopressin. At present, at the age of 18 yr, he 
has a polyuria and polydipsia of approximately 13 L/day (no medication). 
In his older sister, a diagnosis of diabetes insipidus was made at the age 
of a few months. Data on a water-deprivation test or a DDAVP (deamino-
8-D~arginine vasopressin; Minrin®) test were not available in her medical 
record. She has been treated, however, with Minrin® without a reduction 
in urinary volume. Now, as an adult, she has a fluid intake of approxi­
mately 13 L/day (no medication).
Family 2 comes from Sri Lanka. The male proband (Patient 2) was 
referred at the age of 5 months because of intermittent high fever, 
weakness, irritability, and weight loss, The diagnosis of NDI was based 
on the presence of a high serum sodium concentration (186 mmol/L), a 
low urinaiy osmolality (173 mosmol/kg), and unresponsiveness to 
DDAVP. Therapy with hydrochlorothiazide proved very difficult despite 
tube feeding and was complicated by intermittent bulging fontanel, fever, 
and vomiting. The boy failed to thrive and showed muscular hypotonia 
and delayed psychomotor development. At the age of 13 months he was 
readmitted with high fever, seizures, and hypernatremia (173 mmol/L), 
followed by coma. He succumbed two weeks later. MRI and necropsy 
revealed severe brain lesions with necrosis of basal ganglia. Eight months 
later NDI was diagnosed in the younger brother at the age of I wk based 
on elevated serum sodium (147 mmol/L) and low urinary osmolality (107 
mosmol/kg). At present, at the age of 2 yr, his psychomotor development 
is adequate but there is slight muscular hypotonia. Fluid intake is 2 L/day.
Family 3 is Turkish by descent. In the female proband (Patient 3), 
the diagnosis diabetes insipidus was made at the age of 6 wk when she 
was admitted to the children’s hospital with failure to thrive and signs 
of dehydration, including fever, and hypernatremia (serum sodium 
concentration, 162 mmol/L). Urinary osmolality was low (82 mosmoi/ 
kg) but increased to 236 mosmol/kg after water deprivation and to 450 
mosmol/kg after administration of arginine vasopressin, suggesting a 
diagnosis of nephrogenic diabetes insipidus with partial resistance to 
vasopressin. However, at the age of 18 months, a control vasopressin 
test showed a rise of urine osmolality to only 239 mosmol/kg. Ac­
cording to the parents, two sons of the sister of the paternal grand­
mother, at that time 7 and 8 yr old, both suffered from a similar 
disease. Further investigation revealed that they both had NDI with 
total resistance to vasopressin. All three patients have been treated 
with the combination indomethacin'hydrochlorothiazide, which was 
replaced for amiloride and Minrin® in the proband at the age of 4 yr. 
Despite treatment, she still had a fluid intake of approximately 4 L/day 
at that age.
DNA Amplification and Sequence Analysis o f  Patients
Genomic DNA was isolated by the salt-extraction technique. Prim­
ers used for amplification of the AQP2 coding regions and for cycle 
sequencing were as described elsewhere (15). PCR conditions were 1 
min at 92°C, 1.5 min at 60°C, and 1.5 min at 72°C for 30 cycles. 
Cycle sequencing reactions were performed on both DNA strands, and 
sequences were analyzed on an automated fluorescence-based Ap­
plied Biosystems model 373A DNA sequencing system.
DNA Constructs and  Transcription
To introduce the A147T mutation in our AQP2 expression con­
struct (pT7TsAQP2), exon 2 of the AQP2 gene was amplified from 
genomic DNA of Patient 1. A 66-base pair (bp) SacVSmal fragment 
containing the G to A transition at position 533 was isolated by gel 
electrophoresis. For the T126M mutation, genomic DNA of Patient 2 
was amplified using primers flanking the coding region of exon 2, and 
a 43-bp DdebSacl fragment was isolated, containing the C to T 
transition at position 471, For the N68S mutation, exon 1 of the AQP2 
gene was amplified from genomic DNA of Patient 3, and a 144-bp 
ApciI-SacII fragment containing the A to G transition at position 297 
was isolated. These fragments were inserted into the corresponding 
sites of pT7TsAQP2 and clones that were identical to the wild-type 
(wt) AQP2 cDNA sequence, except for the described mutations, were 
selected by sequence analysis (18). These constructs were linearized 
by Sail and capped RNA transcripts were synthesized in vitro using 
T7 RNA polymerase according to Promega’s (1991) Protocols and 
Principles guide, except that 1-mM final concentrations of NTP and 
7-methyl-di-guanosine triphosphate were used. The cRNA were pu­
rified and dissolved in diethyl pyrocarbonate-treated water. The in­
tegrity of the RNA was checked by agarose gel electrophoresis and 
the concentration was determined spectrophotometrically.
W ater Permeability
Xenopus Laevis oocytes were isolated, injected with 10 ng cRNA and 
analyzed after 3 days in a swelling assay as described before (15). Oocyte 
swelling was performed at 22°C after transfer from 200 mosM to 70 
mosM (wt AQP2 expressing oocytes) or 200 mosM to 20 mosM (water- 
injected confrol oocytes and mutant AQP2 expressing oocytes).
Northern Blot Analysis
At the day of injection and 3 days after injection, RN A was isolated 
from six oocytes according to Chomczynski and Sacchi (19). RNA 
equivalents of three oocytes were loaded onto a 2,2 M formaldehyde, 
1% (wt/vol) agarose gel. Electrophoresis, blotting, and hybridization 
conditions were as described (20). A 850-bp EcoRl cDNA fragment 
encoding human AQP2 (15) was labeled with [a-32P] dCTP by 
random priming (21) and was used as a probe. The relative amount of 
mRNA loaded onto the gel was assessed by hybridization of the same 
blot with a probe of a 780-bp EcoRL-BamHl cDNA fragment coding 
for Xenopus laevis Histon H3 (22) and subsequent scanning of the 
autoradiographic signals with an LKB Ultrascan XL laser densitom­
eter (Pharmacia Biotech, Uppsala, Sweden).
Immunoblotting
To determine the stability of mutant and wt AQP2 proteins, eight 
oocytes were homogenized in 20 /¿L buffer A per oocyte (20 mM Tris 
[pH 7.4], 5 mM MgCl2, 5 mM NaHP04, 1 mM EDTA, 1 mM 
dithiothreitol [DTT], 1 mM phenylmethyl sulfonyl fluoride [PMSF], 5 
ju,g/mL leupeptin and pepstatin, 80 mM sucrose) at 4°C at 1, 2, and 3 
days after injection. Subsequently, the lysates were centrifuged twice 
for 10 min at 125 g to remove yolk proteins. At the third day after 
injection, a fraction enriched for plasma membranes was isolated from 
25 oocytes according to Wall and Patel (23),
Lysates or plasma membranes equivalent to 0,1 oocyte or eight oo­
cytes, respectively, were denatured for 30 min at 37°C in sample buffer 
(2% sodium dodecyl sulfate [SDS], 50 mM Tris (pH 6.8), 12% glycerol,
0.01% Coomassie Brilliant Blue, 100 mM DTT), electrophoresed 
dirough a 12% SDS-polyacrylamide gel (24) and transferred to a nitro­
cellulose membrane as described (15). Efficiency of protein transfer was 
checked by staining the membrane with Ponceau Red. For immunode­
tection, the membrane was incubated with a 1:10,000 dilution of an
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affinity-purified polyclonal antibody directed against the 15 C-terminal 
amino acids of rat AQP2 (17). As a secondary antibody, a 1:5,000 
dilution of affini ty-purified goat-anti-rabbit IgG conjugated to horse rad­
ish peroxidase (Sigma Immuno Chemicals, St. Louis, MO) was used. 
Proteins were visualized using enhanced chemiluminescence (Boehringer 
Mannheim). When appropriate, the 29- and 32-kd AQP2 bands of the 
third day were scanned as described above.
Immuno cytochemistry
At 3 days after injection, remaining vitelline membranes were 
removed and oocytes were incubated for 1 h in 1% wt/vol parafor­
maldehyde fixative (PLP) (25), dehydrated, and embedded in paraffin. 
After being blocked with 10% goat serum in Tris-buffered saline 
(TBS), the sections were incubated O/N at 4°C with the polyclonal 
AQP2 diluted 1:500 in 10% goat serum in TBS. After three washes for 
10 min in TBS, the sections were incubated for 1 h in a 1:100 dilution 
of goat-anti-rabbit IgG coupled to fluorescein isothiocyanate (Sigma 
Immuno Chemicals). The sections were again washed three times for 
10 min, dehydrated by washing in 70% to 100% ethanol, and mounted 
in mowiol 4 -88 , containing 2.5% NaN3, Photographs were taken 
with a Zeiss Axioskop (Zeiss, Oberkochen, Germany) with epifluo- 
rescent illumination with an automatic camera using Kodak EPH 
P1600X films (Eastman Kodak, Rochester, NY).
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Figure 1. Proposed membrane topology of AQP2. The three amino 
acid substitutions as coded for by the AQP2 genes of the three NDI 
patients and the conserved NPA boxes are indicated. The previously 
reported amino acid substitutions in NDI patients (15,16) are shown 
between brackets.
fjim/s) was not different from water-injected control oocytes
Results (8.9 2.2 /¿m/s), whereas oocytes expressing the T126M
From three NDI patients, in whom a V2 receptor defect was (41.4 ±  3.8 fim/s) or A147T (46.2 ± 2,1 p m/s) AQP2 proteins
either excluded or unlikely, we amplified and sequenced the showed a significantly increased water permeability when
four exons of the AQP2 gene. All patients were found to be compared with water-injected control oocytes,
homozygous for three different missense mutations. In Patient The water permeability of wild-type (wt) AQP2 injected
1, a G533A transition was found in exon 2, leading to a oocytes was 275 ± 9.7 pm/s (Figure 2). The low or absent
substitution of an alanine for threonine (A147T). In Patient 2, water permeability of mutant AQP2 proteins in Xenopus oo-
a C47 IT transition in exon 2 leads to a threonine to methionine cytes could be caused by (1) a low stability of the mutant
substitution (T126M). The AQP2 gene of patient 3 showed a c&NAs in Xenopus oocytes; (2) a low stability of the mutant
A297G transition in exon 1, which results in a substitution of AQP2 proteins in oocytes; (3) an impairment of the routing of
an asparagine for a serine (N68S) in one of the most conserved mutant AQP2 proteins to the plasma membrane; and/or (4)
regions of the MIP family proteins (26) (Figure 1).
The asymptomatic parents and a healthy brother and sister of
a mutant AQP2 protein that is a non-functional water channel. 
To test for differences in stability of wt and mutant cRNA,
10 ng AQP-2
water
10 ng A147T %
Patient 1 were shown to be heterozygous for the A147T mu- RNA isolated from oocytes directly after, and 3 days after
tation; another asymptomatic sister appeared to be homozy­
gous for the normal allele. As expected, the affected brother of 
Patient 2 appeared homozygous for the T126M mutation as 
well, whereas their asymptomatic parents were both shown to 
heterozygous for that mutation. DNA of an elder healthy 
brother was not available for testing. Sequencing of exon 1 in 
the two affected male family members of Patient 3 revealed 
that they both were homozygous for the N68S mutation. The 
asymptomatic parents, an asymptomatic sister of the father and 
the paternal grandparents of Patient 3, as well as the mother of 
the two other patients in family 3, were all shown to be 
heterozygous for the N68S mutation. The data are consistent 
with co-segregation of the mutant AQP2 allele with the disease 
and with autosomal recessive inheritance of NDI in these 
families.
To test whether these mutant AQP2 proteins are functional 
water channels, PCR fragments containing the mutations were 
cloned into the AQP2 expression vector and transcripts were 
injected into Xenopus oocytes. Three days later, water perme­
ability measurements revealed that the water permeability 
(Pf ±  SE) of oocytes expressing the N68S mutant (8.3 ±  1.9
10 ng T126M
10 ng N68S
1  *
0 50 100 150 200 250 
P (jim/s)
300
Figure 2. Osmotic water permeability (Pf) of oocytes 3 days after 
injection of water or 10 ng cRNA encoding wt, A147T, T126M, or 
N68S AQP2. Mean and SE of at least 45 oocytes from six different 
experiments are shown (*, significantly increased above water-in­
jected control oocytes; P <  0.01).
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injection was subjected to Northern blot analysis. A specific 
signal with our human AQP2 cDNA probe was only obtained 
in lanes loaded with'RNA isolated from AQP2 cRNA-injected 
oocytes (Figure 3). 'After normalization for the amounts of 
RNA loaded by hybridization with a Xenopus Histon H3 probe,
*
the amounts of wt and mutant AQP2 cRNAs were comparable.
To compare the size and stability of mutant and wt AQP2 
proteins, oocyte lysates were prepared 1, 2, and 3 days after 
injection and were subjected to immunoblotting using AQP2 
antibodies (Figure 4). Ponceau Red staining of the immunoblot 
showed that equal amounts of protein were loaded (not shown), 
Chemiluminescence detection revealed a band of 29-kd present 
in all lanes loaded with AQP2 protein, except in the lane 
loaded with water-injected control oocytes. In the lanes loaded 
with mutant AQP2 protein an additional band of approximately 
32 kd was present. Densitometric scanning of the bands from 
the third day samples revealed that the stability of the T126M 
and N68S mutants and wt AQP2 were equal, whereas the 
stability of the A147T mutant was less than 10% of wt AQP2.
To determine the plasma membrane expression of wt and 
mutant AQP2 proteins, a fraction enriched for plasma mem­
branes was subjected to immunoblotting (Figure 5), Only in the
WT A147T
1 2 3 1 2
T126M N68S
1 2 3 1 2 3
Figure 4. Immunoblot analysis of AQP2 proteins. At 1,2, and 3 days 
after injection, lysates were prepared from eight oocytes injected with 
water or cRNA encoding wt, A147T, T126M, or N68S AQP2. Equiv­
alents of 0J. oocyte were separated by SDS-PAGE and blotted. AQP2 
proteins were visualized by chemiluminescence using AQP2 antibod­
ies as a first antibody and anti-rabbit IgG, conjugated to peroxidase, as 
a second antibody.
membrane fraction of oocytes expressing wt AQP2 was a clear H 2O  y\/"[" A 147T  T 126M  N68S
29-kd band visible, whereas no AQP2 protein could be de­
tected in the membrane fractions of AQP2 mutants. To visu­
alize the location of AQP2 proteins, immunocytochemistry 
was performed on injected oocytes (Figure 6). Staining with 
the AQP2 antibody revealed a clear, intense staining of the 
plasma membrane of oocytes expressing wt AQP2 (Figure 
6A), whereas oocytes expressing mutant AQP2 proteins 
showed a very weak staining of the plasma membrane, with a 
more pronounced labeling of the cytoplasm (Figure 6B-D). 
The water-injected control oocytes showed no staining (Figure 
6E).
L L M L L L  M
<—32<—29
Figure 5, Immunoblot analysis of lysates and a fraction enriched for 
plasma membranes of oocytes. Lysates (L) and plasma membranes 
(M) were prepared 3 days after injection of water or cRNA encoding 
wt, A147T, T126M, or N68S AQP2. Equivalents of 0.1 oocyte (L) or 
eight oocytes (M) were separated by SDS-PAGE and immunoblotted 
as described in the legend of Figure 4.
W T A 147T  T126M N68S
A Q P2
Discussion
The discovery of mutations in the V2 receptor gene, located 
on the X-chromosome, explained the cause of NDI in a ma­
jority of the patients (27), but not in all. Some of these 
unexplained NDI cases appeared to segregate as an autosomal 
recessive trait, and mutations in the V2 receptor coding region 
could often be excluded in these cases. Therefore, the involve­
ment of a second gene causing NDI was likely. In search for 
proteins involved in the cascade of events between the binding 
of vasopressin to the V2 receptor at the basolateral membrane 
and the reabsorption of water at the apical membrane of the 
<— H i s t o n  H3 collecting duct cell, the cloning of the rat AQP2 water channel,
which is exclusively expressed in the collecting duct (2), 
attracted attention. The AQP2 gene was assigned to chromo-
Figure 3. Northern blot analysis of the stabilities of cRNA encoding 
wt, A147T, T126M, or N68S AQP2 in Xenopus oocytes. At the day 
of injection and 3 days after injection, RNA was isolated from six 
oocytes. An equivalent of three oocytes was blotted and RNA was 
visualized using a human AQP2 cDNA probe (upper panel). For 
normalization of the amount of RNA loaded, the blot was hybridized 
with a Xenopus histon H3 probe (lower panel).
some 12, region q l2-q l3 , and was therefore a likely candidate 
(28). The subsequent identification of mutations in the AQP2 
gene in some of these NDI patients provided a definitive proof 
for a second gene defect in NDI (15,16).
Here we report three new mis sense mutations in the AQP2 
gene of three NDI patients coding for a A147T-, T126M-, or 
N68S-substituted AQP2 protein. Expressed in Xenopus 00-
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E
Figure 6, Sections of oocytes injected with cRNA encoding wt (A), A147T (B), T126M (C), or N68S (D) AQP2. As a negative control, 
water-injected control oocytes were used (E). The sections were incubated with AQP2 antibodies and visualized by FITC-conjugated anti-rabbit 
immunoglobulins,
cytes, the N68S mutant AQP2 was non-functional (Figure 2). 
This could be anticipated, because the substituted amino acid is 
part of the NPA box in loop B, which forms, together with a 
second NPA box in loop E, the most conserved amino acid 
sequence of the MIP-family (26). Unlike the N68S-substituted 
protein and previously reported AQP2 mutants (G64R, R187C, 
and S216P) (15,16), the A147T and T126M AQP2 mutant 
proteins were functional. The alanine at position 147 is also
well-conserved among the MIP family members (26). The 
observed water permeability of the oocytes expressing the 
A147T and T126M AQP2 proteins was, however, much lower 
than that of oocytes expressing wt AQP2.
To find an explanation for the reduced Pf of oocytes ex­
pressing NDI-related AQP2 proteins, these oocytes were ana­
lyzed in detail and were compared with wt AQP2~expressing 
oocytes. The stability of injected cRNA was equal for mutant
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and wt AQP2 (Figure 3). In contrast, differences with wt AQP2 
were observed on the protein level. Immunoblot analysis re­
vealed that wt AQP2 was only expressed as a 29-kd protein, 
whereas the three mutants showed an additional 32-kd form 
(Figure 4). In a previous study on mutant AQP2 proteins 
similar 32-kd bands were detected, and they were shown to be 
endoglycosidase H-sensitive (17). Because endoglycosidase H 
hydrolyses endoplasmic reticulum-specific high-mannose gly- 
cosylation groups, the 32-kd bands presumably represent ER- 
retarded forms of mutant AQP2 proteins. The mutant AQP2 
proteins are apparently retained in the endoplasmic reticulum 
and are thus impaired in their routing to the plasma membrane. 
The indication that the A147T-, T126M-, and N68S-substituted 
AQP2 proteins were impaired in their transport was further 
substantiated by the absence of these proteins in an immuno- 
blotted oocyte fraction enriched for plasma membranes, 
whereas the wt AQP2 protein was clearly present (Figure 5). In 
addition, immunocytochemistry showed a clear AQP2 labeling 
in the plasma membrane of oocytes expressing wt AQP2, 
whereas the mutant AQP2 proteins were abundantly expressed 
in the cytoplasm, but were hardly detectable in the plasma 
membrane, which confirms the impaired transport of the mu­
tant AQP2 proteins (Figure 6). In the ER, newly synthesized 
proteins undergo various post-translational modifications, in­
cluding folding, oligomerization, and glycosylation (29,30). 
Proteins that are not properly processed do not pass the “qual­
ity control” of the ER and are usually retained. The processing 
of the new protein depends in part on the structural motifs 
displayed during folding and assembly, and by the molecular 
interactions with chaperones and folding factors. The quality 
control of the ER recognizes certain conformational features of 
the misfolded protein, such as hydrophobic peptide elements 
exposed on the surface of the molecule, and, in most cases, 
misprocessed proteins are subsequently degraded (29-31). In 
Xenopus oocytes, the stability of the T126M and N68S mutants 
was comparable with that of wt AQP2, but the A147T mutant 
was considerably less stable, a phenomenon previously shown 
for the S216P mutant also (17). Because the A147T and S216P 
mutations are both located in a transmembrane domain, mis- 
folding may cause the exposure of hydrophobic regions on the 
surface of the molecule, which could make these mutants more 
accessible to ER-resident proteases. The other mutations 
(G64R, N68S, T126M, and R187C) are located in the more 
hydrophilic extramembranous loops, which may explain their 
stability in oocytes.
In summary, all six NDI-related missense AQP2 proteins 
(G64R, N68S, T126M, A147T, R187C, and S216P) are im­
paired in their transport to the plasma membrane when ex­
pressed in Xenopus oocytes (17; this study). Despite the im­
pairment in routing, the A147T and T126M mutants 
significantly increased the Pf of oocytes. In view of the fact 
that the A147T mutant is very unstable in oocytes, the mutants 
that are stable in oocytes (G64R, N68S, and R187C) should 
also confer water permeability to oocytes, if they were func­
tional water channels. Therefore, it is likely that the G64R, 
N68S and R187C AQP2 mutants are nonfunctional.
All of our data regarding AQP2 are in line with the hourglass 
model, which is a structural-functional model proposed for
AQP1. In this model, loops B and E are essential for the 
formation of the pore through which water transport takes 
place (32). The hourglass model is based on site-directed 
mutagenesis studies in which mutations in the B and E loops of 
AQP1, containing the conserved NPA boxes, resulted in loss of 
water permeability. Mutations in the A, C, and D loops and the 
N- and C-terminal regions, however, affected the water trans­
porting properties of AQP1 to a lesser degree (33). All AQP2 
proteins in NDI with mutations in the B loop (G64R, N68S) or 
E loop (R187C) are nonfunctional, whereas AQP2 proteins 
with mutations in the C loop (T126M) or near the D loop 
(A147T) are functional. Recently, Bai et a l  (34) proposed that 
in AQP2 loops C and D are closely located to the aqueous 
pathway, instead of loops B and E. This is not in line with our 
data from NDI-related mutant AQP2 proteins. Bai et a l  (34) 
reported that mutations near the NPA boxes in loops B and E 
did not alter water channel function, which contrasts sharply 
with our data.
In conclusion, two mutant AQP2 proteins, encoded by 
AQP2 genes of patients suffering from autosomal recessive 
NDI, appeared to be functional water channels. Therefore, the 
major cause underlying this disease is the misrouting of the 
mutant AQP2 proteins, and not the dysfunction of the water 
channels. As shown for the most common mutant form of the 
cystic fibrosis transmembrane conductance regulator (CFTR), 
which has a deletion of the phenylalanine at position 508, the 
primary effect is not a functional impairment, but rather an 
impairment in the routing of the mutant protein to the plasma 
membrane. In CFTRAF508-expressing cells it has been shown 
that culturing cells at lower temperatures relieved the impair­
ment in routing of the AF508 mutant, which resulted in the 
appearance of functional Cl-  channels in the plasma mem­
brane (35). Furthermore, elevated levels of molecular chaper­
ones appeared to increase proper folding of the K304E mutant 
of the medium chain acyl-CoA dehydrogenase (MCAD) (36) 
and the Y393N mutation of the E l a: subunit of the mitochon­
drial branched chain a-ketoacid dehydrogenase complex (37). 
In future studies, attempts should be undertaken to overcome 
the biosynthetic arrest and to promote trafficking of the T126M 
and A147T AQP2 mutants to subapical vesicles or the plasma 
membrane. This will require knowledge of the mechanism that 
causes retention. The opportunity to manipulate the cellular 
machinery associated with protein folding and trafficking may 
provide the tools for novel pharmacotherapeutic strategies diat 
may be used in the treatment of this form of nephrogenic 
diabetes insipidus.
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